Cellipont Bioservices, a cell therapy contract development and manufacturing organization, announced plans to relocate from San Diego to The Woodlands in the first half of 2023.
According to a news release from The Woodlands Area Economic Development Partnership, Cellipont Bioservices will be developing a 76,000-square-foot facility in phases, with the first phase being scheduled to begin operation in the first half of 2023.
"Cellipont is excited to move forward with this next stage of our company’s development as a best-in-class cell therapy CDMO. As our client programs advance through the clinic and toward commercialization, we are working diligently to offer them state-of-the-art facilities and capabilities. This site near Houston is an ideal location to serve clients and patients across all of North America, with two major airports and a strong local workforce,” said Deborah Wild, chief executive officer at Cellipont Bioservices, in the release.
Ashley Byers, director of marketing and outreach for The Woodlands Area EDP, said the partnership facilitated the relocation.
